Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women

Knekt, 2008, Serum vitamin D and subsequent occurrence of type 2 diabetes, Epidemiology, 19, 666, 10.1097/EDE.0b013e318176b8ad Dobnig, 2008, Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality, Arch Intern Med, 168, 1340, 10.1001/archinte.168.12.1340 Giovannucci, 2008, 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study, Arch Intern Med, 168, 1174, 10.1001/archinte.168.11.1174 Wang, 2008, Vitamin D deficiency and risk of cardiovascular disease, Circulation, 117, 503, 10.1161/CIRCULATIONAHA.107.706127 Zittermann, 2003, Vitamin D in preventive medicine: are we ignoring the evidence?, Br J Nutr, 89, 552, 10.1079/BJN2003837 Norman, 1980, Vitamin D deficiency inhibits pancreatic secretion of insulin, Science, 209, 823, 10.1126/science.6250216 Kadowaki, 1984, Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas, J Clin Invest, 73, 759, 10.1172/JCI111269 Cheng, 2010, Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study, Diabetes, 59, 242, 10.2337/db09-1011 Gulseth, 2010, Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome, Diabetes Care, 33, 923, 10.2337/dc09-1692 Scragg, 2004, Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey, Diabetes Care, 27, 2813, 10.2337/diacare.27.12.2813 Chiu, 2004, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction, Am J Clin Nutr, 79, 820, 10.1093/ajcn/79.5.820 Forouhi, 2008, Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000, Diabetes, 57, 2619, 10.2337/db08-0593 Kayaniyil, 2010, Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes, Diabetes Care, 33, 1379, 10.2337/dc09-2321 Karhapää, 2010, Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias, J Intern Med, 268, 604, 10.1111/j.1365-2796.2010.02279.x Martins, 2007, Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey, Arch Intern Med, 167, 1159, 10.1001/archinte.167.11.1159 Ford, 2005, Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults, Diabetes Care, 28, 1228, 10.2337/diacare.28.5.1228 Anderson, 2003, Implementation of the Women’s Health Initiative study design, Ann Epidemiol, 13, S5, 10.1016/S1047-2797(03)00043-7 Hays, 2003, The Women’s Health Initiative recruitment methods and results, Ann Epidemiol, 13, S18, 10.1016/S1047-2797(03)00042-5 Jackson, 2006, Calcium plus vitamin D supplementation and the risk of fractures, N Engl J Med, 354, 669, 10.1056/NEJMoa055218 Chlebowski, 2008, Calcium plus vitamin D supplementation and the risk of breast cancer, J Natl Cancer Inst, 100, 1581, 10.1093/jnci/djn360 Wactawski-Wende, 2006, Calcium plus vitamin D supplementation and the risk of colorectal cancer, N Engl J Med, 354, 684, 10.1056/NEJMoa055222 Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. 2009;120:1640–5. Steiner, 1981, Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the Lipid Clinics methodology, J Clin Chem, 19, 850 Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Wallace, 2004, Use and abuse of HOMA modeling, Diabetes Care, 27, 1487, 10.2337/diacare.27.6.1487 Zittermann, 2006, Vitamin D and disease prevention with special reference to cardiovascular disease, Prog Biophys Mol Biol, 92, 39, 10.1016/j.pbiomolbio.2006.02.001 Ross, 2011, The 2011 report on dietary reference intakes for calcium and vitamin d from the Institute of Medicine: what clinicians need to know, J Clin Endocrinol Metab, 96, 53, 10.1210/jc.2010-2704 Holick, 2007, Vitamin D deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553 Greenland, 1995, Dose-response and trend analysis in epidemiology: alternatives to categorical analysis, Epidemiology, 6, 356, 10.1097/00001648-199507000-00005 IOM. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press, 2011. Gaziano, 1997, Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction, Circulation, 96, 2520, 10.1161/01.CIR.96.8.2520 Liu, 2009, Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults, J Nutr, 139, 329, 10.3945/jn.108.093831 Gannage-Yared, 2009, Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population, Eur J Endocrinol, 160, 965, 10.1530/EJE-08-0952 Lu, 2009, Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals, Diabetes Care, 32, 1278, 10.2337/dc09-0209 Pinelli, 2010, Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans, Diabetes Care, 33, 1373, 10.2337/dc09-2199 Johnson, 2010, Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients, J Pediatr, 156, 444, 10.1016/j.jpeds.2009.09.070 Hypponen, 2006, Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity, Diabetes Care, 29, 2244, 10.2337/dc06-0946 Rodríguez-Rodríguez E, Ortega RM, González-Rodríguez LG, López-Sobaler AM; UCM Research Group VALORNUT (920030). Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children. Eur J Nutr (Epub ahead of print 20 November 2010). Reis, 2009, Vitamin D status and cardiometabolic risk factors in the United States adolescent population, Pediatrics, 124, e371, 10.1542/peds.2009-0213 Botella-Carretero, 2007, Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity, Clin Nutr, 26, 573, 10.1016/j.clnu.2007.05.009 Hypponen, 2008, 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort, Diabetes, 57, 298, 10.2337/db07-1122 Barger-Lux, 1995, An investigation of sources of variation in calcium absorption efficiency, J Clin Endocrinol Metab, 80, 406 Welberg, 1994, Effects of supplemental dietary calcium on quantitative and qualitative fecal fat excretion in man, Ann Nutr Metab, 38, 185, 10.1159/000177810 Vaskonen, 2002, Effects of calcium and plant sterols on serum lipids in obese Zucker rats on a low-fat diet, Br J Nutr, 87, 239, 10.1079/BJN2001508 Cho, 2005, The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes, Biol Pharm Bull, 28, 1418, 10.1248/bpb.28.1418 Lips, 2001, Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications, Endocr Rev, 22, 477, 10.1210/edrv.22.4.0437 Lacour, 1982, Parathyroid function and lipid metabolism in the rat, Miner Electrolyte Metab, 7, 157 Zittermann, 2009, Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers, Am J Clin Nutr, 89, 1321, 10.3945/ajcn.2008.27004 Rajpathak, 2010, Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women’s Health Initiative, Am J Clin Nutr, 91, 894, 10.3945/ajcn.2009.28579 Andersen, 2009, Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants, Eur J Clin Nutr, 63, 1150, 10.1038/ejcn.2009.18 Johnson, 1994, Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas, Am J Physiol, 267, E356 Maestro, 2000, Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells, Endocr J, 47, 383, 10.1507/endocrj.47.383 Lind, 1989, Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure, Diabetes Res, 11, 141 Orwoll, 1994, Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus, Am J Clin Nutr, 59, 1083, 10.1093/ajcn/59.5.1083 Fliser, 1997, No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects, Eur J Clin Invest, 27, 629, 10.1046/j.1365-2362.1997.1520699.x Borissova, 2003, The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients, Int J Clin Pract, 57, 258, 10.1111/j.1742-1241.2003.tb10480.x Nilas, 1984, Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women, Int J Obes, 8, 407 Pittas, 2007, The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults, Diabetes Care, 30, 980, 10.2337/dc06-1994 de Boer, 2008, Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women’s Health Initiative, Diabetes Care, 31, 701, 10.2337/dc07-1829 Hsia, 2007, Calcium/vitamin D supplementation and cardiovascular events, Circulation, 115, 846, 10.1161/CIRCULATIONAHA.106.673491 Pittas, 2010, Systematic review: vitamin D and cardiometabolic outcomes, Ann Intern Med, 152, 307, 10.7326/0003-4819-152-5-201003020-00009 Wortsman, 2000, Decreased bioavailability of vitamin D in obesity, Am J Clin Nutr, 72, 690, 10.1093/ajcn/72.3.690 Reis, 2007, Vitamin d, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults, Diabetes Care, 30, 1549, 10.2337/dc06-2438 Rueda, 2008, PTH, and the metabolic syndrome in severely obese subjects, Obes Surg, 18, 151, 10.1007/s11695-007-9352-3 Hjelmesaeth, 2009, Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study, Cardiovasc Diabetol, 8, 7, 10.1186/1475-2840-8-7 Ford, 2009, Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States, J Diabetes, 1, 296, 10.1111/j.1753-0407.2009.00046.x Kim, 2010, The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects, Clin Endocrinol (Oxf), 73, 330, 10.1111/j.1365-2265.2010.03798.x Reis, 2008, Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults, Eur J Endocrinol, 159, 41, 10.1530/EJE-08-0072